Domicile
Reels
Groupes
Pages
Plus
Groupes Pages Evènements Blogs Financement
Se connecter S’enregistrer
Mode nuit
How Are Disease-Modifying Biologics Transforming Pulmonary Arterial Hypertension Treatment?
For decades, PAH treatment relied on vasodilators that managed symptoms but did not address the underlying disease process. Disease-modifying biologics are transforming PAH treatment by targeting the vascular remodeling that drives disease progression, offering the potential for improved long-term outcomes. This innovation is a major driver of growth in the Pulmonary Arterial Hypertension...
0 Commentaires ·0 Parts ·135 Vue ·0 Aperçu
Connectez-vous pour aimer, partager et commenter!